Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00633633 · ClinicalTrials.gov registry record · NA

Lifestyle Intervention for Heart Failure

A NA study of Heart Failure, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
85
Enrollment target
2
Study locations

NCT00633633: Active NA study of Heart Failure, sponsored by M.D. Anderson Cancer Center.

NCT00633633 is a NA study of Heart Failure that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 85 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00633633, a NA study of Heart Failure, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
85 participants
Enrollment target
2
Study locations

Study Summary

The goal of this behavioral research study is to learn if education and training about exercise can help to change the lifestyle of cancer survivors with symptoms of heart failure.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise Training
  • OTHER Usual Care
  • BEHAVIORAL Dietary Counseling

Study Locations (2)

Texas

  • University of Texas MD Anderson Cancer Center - Houston
  • The University of Texas Health Science Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2008-02-11
Est. Completion 2026-05-31
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the registry record for NCT00633633 still lists

NCT00633633 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 3 interventions - of which Exercise Training is the first listed.

NCT00633633 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00633633 about?

NCT00633633 is a clinical study titled "Lifestyle Intervention for Heart Failure". The goal of this behavioral research study is to learn if education and training about exercise can help to change the lifestyle of cancer survivors with symptoms of heart failure.

What is the current status of trial NCT00633633?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2008-02-11. Estimated completion is 2026-05-31.

What conditions does trial NCT00633633 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT00633633?

The interventions under investigation include: Exercise Training (BEHAVIORAL), Usual Care (OTHER), Dietary Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT00633633?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00633633 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00633633's enrollment target sits among peer trials

85 226th of 397 higher than 171 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00842283 · 85 participants

    Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

  • NCT02133196 · 85 participants · Phase 2

    T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

  • NCT03823144 · 85 participants · NA

    Intravital Microscopy in Human Solid Tumors

  • NCT03875638 · 85 participants · Phase 2

    Treating Hyperexcitability in AD With Levetiracetam

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00633633, the US trial registry maintained by the National Library of Medicine. NCT00633633 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.